FIGURE 4.
Paeoniflorin (PF) promoted cell function in TBHP-treated HUVECs. (A,D) Evaluation of PF-mediated HUVEC neovascularization using tube formation assay (scale bar, 100 μm). (B,E) Assessment of PF-mediated HUVEC migration using the transwell system (scale bar, 100 μm). (C,F) Evaluation of PF-mediated HUVEC adhesion using cell-matrix adhesion assay (scale bar, 100 μm). Data: mean ± SD, *p < 0.05 and **p < 0.01. n = 3.